트랜스펙션 시약 및 장비 시장 : 제품, 방법, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Transfection Reagents & Equipment Market was valued at USD 2.48 billion in 2023, expected to reach USD 2.79 billion in 2024, and is projected to grow at a CAGR of 12.76%, to USD 5.76 billion by 2030.

Transfection reagents and equipment are essential for introducing nucleic acids into cells, either to study gene function or to produce proteins. The scope of transfection covers a range of techniques and utilities across research and clinical laboratories, ensuring critical applications in gene therapy, cancer research, and protein synthesis. These tools are indispensable for advancing medical research and biotechnological developments. Their necessity lies in the precision and efficiency offered in genetic engineering, facilitating advancements in personalized medicine, drug discovery, and biotechnology. The end-use scope of this market encompasses academic research institutions, biotechnology companies, pharmaceutical industries, and clinical research organizations, each driving demand with unique application needs.

Key growth influencers include the escalating R&D investments in life sciences, a growing focus on precision medicine, and the surge in genetic disorder studies. Rapid advancements in technology are fostering automation in transfection technologies, offering new opportunities for efficiency gain. However, market growth is challenged by high costs associated with equipment and reagents, complex regulatory frameworks, and limited transfection agent efficiency in certain cell lines, which could hinder widespread adoption. Emerging opportunities lie in developing more cost-effective and less toxic transfection methods and expanding applications in gene editing technologies like CRISPR-Cas9.

Innovative avenues for business growth are underscored by expanding into developing markets, investing in R&D for novel reagent formulations to increase transfection efficiency, and focusing on collaborations for technology advancement. Understanding the market's competitive nature, characterized by a few dominant players and numerous small niche companies, can guide strategic positioning. Companies are recommended to prioritize eco-friendly and sustainable practices in product development to align with global consumer trends. Enhanced customer education initiatives can also facilitate broader end-user adoption by simplifying complex transfection techniques. By embracing these strategies, businesses can position themselves to harness the market's potential while mitigating inherent growth challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transfection Reagents & Equipment Market

The Transfection Reagents & Equipment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising Research Activities in the Field of Cell Science
  • Growing Prevalence of Cancer Worldwide
  • Large-Scale Transfection of Mammalian Cells for the Faster Generation of Recombinant Protein
• Market Restraints
  • Effect of Serum in Media and Cell Confluency on Efficiency of Transfection
• Market Opportunities
  • Recent Advancements in Transfection Technology
  • Increasing R&D and Facility Expansion Activities by Pharmaceutical and Biotech Companies
• Market Challenges
  • Maintenance of Higher Level of Biological Safety

Porter's Five Forces: A Strategic Tool for Navigating the Transfection Reagents & Equipment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transfection Reagents & Equipment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transfection Reagents & Equipment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transfection Reagents & Equipment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transfection Reagents & Equipment Market

A detailed market share analysis in the Transfection Reagents & Equipment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transfection Reagents & Equipment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transfection Reagents & Equipment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Transfection Reagents & Equipment Market, highlighting leading vendors and their innovative profiles. These include BioVision, Inc., Qiagen N.V., Lonza Group Ltd., Altogen Biosystems, IBA Lifesciences GmbH, GeneCopoeia, Inc., F. Hoffmann-La Roche AG, Agilent Technologies, Inc., MaxCyte, Inc., Mirus Bio LLC, SBS Genetech Co., Ltd., Active Motif, Inc., TransGen Biotech Co., Ltd., Tecan Trading AG, Bex Co., Ltd., Bio-Rad Laboratories, Inc., Applied Biological Materials Inc., Merck KGaA, Polyplus-Transfection SA by Sartorius AG, Promega Corporation, PerkinElmer, Inc., Takara Bio Inc., Danaher Corporation, Fugent, LLC, Sutter Instrument Co., OriGene Technologies Inc., Thermo Fisher Scientific Inc., Omega Bio-tek, Inc., and Sartorius AG.

Market Segmentation & Coverage

This research report categorizes the Transfection Reagents & Equipment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Equipment and Reagents.
• Based on Method, market is studied across Biochemical Methods, Physical Methods, and Viral Methods. The Biochemical Methods is further studied across Calcium Phosphate, Deae-Dextran, Dendrimers, and Lipofection. The Physical Methods is further studied across Electroporation, Genegun, Magnetofection, Nucleofection, Optoinjection, and Sonoporation. The Viral Methods is further studied across Adenoassociated Viruses, Adenoviruses, and Retroviruses.
• Based on Application, market is studied across Biomedical Research, Protein Production, and Therapeutic Delivery.
• Based on End User, market is studied across Academics & Research Institutes and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising Research Activities in the Field of Cell Science
    • 5.1.1.2. Growing Prevalence of Cancer Worldwide
    • 5.1.1.3. Large-Scale Transfection of Mammalian Cells for the Faster Generation of Recombinant Protein
  • 5.1.2. Restraints
    • 5.1.2.1. Effect of Serum in Media and Cell Confluency on Efficiency of Transfection
  • 5.1.3. Opportunities
    • 5.1.3.1. Recent Advancements in Transfection Technology
    • 5.1.3.2. Increasing R&D and Facility Expansion Activities by Pharmaceutical and Biotech Companies
  • 5.1.4. Challenges
    • 5.1.4.1. Maintenance of Higher Level of Biological Safety
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing usage of transfection reagents to facilitate or enhance the delivery of genetic materials
  • 5.2.2. End User: High potential of transfection reagents & equipment across pharmaceutical & biotechnology companies for the development of vaccines and gene therapies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Transfection Reagents & Equipment Market, by Product

• 6.1. Introduction
• 6.2. Equipment
• 6.3. Reagents

7. Transfection Reagents & Equipment Market, by Method

• 7.1. Introduction
• 7.2. Biochemical Methods
  • 7.2.1. Calcium Phosphate
  • 7.2.2. Deae-Dextran
  • 7.2.3. Dendrimers
  • 7.2.4. Lipofection
• 7.3. Physical Methods
  • 7.3.1. Electroporation
  • 7.3.2. Genegun
  • 7.3.3. Magnetofection
  • 7.3.4. Nucleofection
  • 7.3.5. Optoinjection
  • 7.3.6. Sonoporation
• 7.4. Viral Methods
  • 7.4.1. Adenoassociated Viruses
  • 7.4.2. Adenoviruses
  • 7.4.3. Retroviruses

8. Transfection Reagents & Equipment Market, by Application

• 8.1. Introduction
• 8.2. Biomedical Research
• 8.3. Protein Production
• 8.4. Therapeutic Delivery

9. Transfection Reagents & Equipment Market, by End User

• 9.1. Introduction
• 9.2. Academics & Research Institutes
• 9.3. Pharmaceutical & Biotechnology Companies

10. Americas Transfection Reagents & Equipment Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Transfection Reagents & Equipment Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Transfection Reagents & Equipment Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Polyplus Launches FectoVIR-LV Transfection Reagent with New DOE Service Options
  • 13.3.2. Lungs-Targeted Transfection Reagent Offers Safe and Effective Delivery of Biomolecules
  • 13.3.3. Sartorius to Acquire Polyplus to Strengthen its Position in the Cell and Gene Therapy Market

Companies Mentioned

• 1. BioVision, Inc.
• 2. Qiagen N.V.
• 3. Lonza Group Ltd.
• 4. Altogen Biosystems
• 5. IBA Lifesciences GmbH
• 6. GeneCopoeia, Inc.
• 7. F. Hoffmann-La Roche AG
• 8. Agilent Technologies, Inc.
• 9. MaxCyte, Inc.
• 10. Mirus Bio LLC
• 11. SBS Genetech Co., Ltd.
• 12. Active Motif, Inc.
• 13. TransGen Biotech Co., Ltd.
• 14. Tecan Trading AG
• 15. Bex Co., Ltd.
• 16. Bio-Rad Laboratories, Inc.
• 17. Applied Biological Materials Inc.
• 18. Merck KGaA
• 19. Polyplus-Transfection SA by Sartorius AG
• 20. Promega Corporation
• 21. PerkinElmer, Inc.
• 22. Takara Bio Inc.
• 23. Danaher Corporation
• 24. Fugent, LLC
• 25. Sutter Instrument Co.
• 26. OriGene Technologies Inc.
• 27. Thermo Fisher Scientific Inc.
• 28. Omega Bio-tek, Inc.
• 29. Sartorius AG